Following recent advocacy wins and congressional engagement in Washington, D.C., this session breaks down the latest policy updates, congressional conversations, and regulatory shifts shaping the future of POC. Experts will examine emerging developments impacting pharma marketing, broader healthcare policy changes influencing DTC advertising, and critical trends to monitor.